Application | Comment | Organism |
---|---|---|
medicine | ADAM17 is a potential drug target in tumor necrosis factor and/or epidermal growth factor receptordependent pathologies in inflammation and cancer | Mus musculus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
membrane | - |
Mus musculus | 16020 | - |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
epidermal growth factor receptor + H2O | Mus musculus | - |
? | - |
? | |
L-selectin + H2O | Mus musculus | - |
? | - |
? | |
proTNF-alpha + H2O | Mus musculus | - |
soluble TNF-alpha + ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
epidermal growth factor receptor + H2O | - |
Mus musculus | ? | - |
? | |
L-selectin + H2O | - |
Mus musculus | ? | - |
? | |
proTNF-alpha + H2O | - |
Mus musculus | soluble TNF-alpha + ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
a disintegrin and metalloprotease 17 | - |
Mus musculus |
ADAM17 | - |
Mus musculus |
Organism | Comment | Expression |
---|---|---|
Mus musculus | ADAM17 is expressed in most tissues and is up-regulated during inflammation and cancer | up |
General Information | Comment | Organism |
---|---|---|
malfunction | ADAM17-deficient mice are not viable. Mice with dramatically reduced ADAM17 levels show substantially increased susceptibility to inflammation in dextran sulfate sodium colitis and develop eye, heart, and skin defects | Mus musculus |
physiological function | ADAM17 is needed for vital regenerative activities during the immune response. ADAM17 is not crucial for developmental Notch or Notch ligand function in vivo | Mus musculus |